Nephrology News
Cytoreductive Nephrectomy Improves Survival in mRCC
Propensity score matching showed a 5.8 month survival advantage for initial CN vs initial systematic therapy.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/